| Literature DB >> 29946347 |
Richard P G Ten Broek1,2, Pepijn Krielen1, Salomone Di Saverio3, Federico Coccolini4, Walter L Biffl5, Luca Ansaloni4, George C Velmahos6, Massimo Sartelli7, Gustavo P Fraga8, Michael D Kelly9, Frederick A Moore10, Andrew B Peitzman11, Ari Leppaniemi12, Ernest E Moore13, Johannes Jeekel14, Yoram Kluger15, Michael Sugrue16, Zsolt J Balogh17, Cino Bendinelli18, Ian Civil19, Raul Coimbra20, Mark De Moya21, Paula Ferrada22, Kenji Inaba23, Rao Ivatury22, Rifat Latifi24, Jeffry L Kashuk25, Andrew W Kirkpatrick26, Ron Maier27, Sandro Rizoli28, Boris Sakakushev29, Thomas Scalea30, Kjetil Søreide31,32, Dieter Weber33, Imtiaz Wani34, Fikri M Abu-Zidan35, Nicola De'Angelis36, Frank Piscioneri37, Joseph M Galante38, Fausto Catena39, Harry van Goor1.
Abstract
Background: Adhesive small bowel obstruction (ASBO) is a common surgical emergency, causing high morbidity and even some mortality. The adhesions causing such bowel obstructions are typically the footprints of previous abdominal surgical procedures. The present paper presents a revised version of the Bologna guidelines to evidence-based diagnosis and treatment of ASBO. The working group has added paragraphs on prevention of ASBO and special patient groups.Entities:
Keywords: Adhesions; Laparoscopy; Laparotomy; Small bowel obstruction; Surgery
Mesh:
Year: 2018 PMID: 29946347 PMCID: PMC6006983 DOI: 10.1186/s13017-018-0185-2
Source DB: PubMed Journal: World J Emerg Surg ISSN: 1749-7922 Impact factor: 5.469
Classification of evidence per article
| Level of evidence | Interventional research | Studies concerning diagnostic accuracy | Studies on complications or side effects, etiology, prognosis |
|---|---|---|---|
| A1 | Systematic review/meta-analysis of at least 2 independently performed level A2 studies | ||
| A2 | Double-blind controlled randomized comparative clinical trial of good study quality with an adequate number of study participants | Diagnostic test compared to reference test; criteria and outcomes defined in advance; assessment of test results by independent observers; independent interpretation of test results; adequate number of consecutive patients enrolled; all patients subjected to both tests | Prospective cohort with sufficient amount of study participants and follow-up, adequately controlled for confounders; selection in follow-up has been successfully excluded |
| B | Comparative studies, but without all the features mentioned for level A2 (including patient-control studies, cohort studies) | Diagnostic test compared to reference test, but without all the features mentioned in A2 | Prospective cohort study, but without all the features mentioned for level A2 or retrospective cohort study or case-control study |
| C | Noncomparative studies | ||
| D | Expert opinion | ||
Grading of the conclusions and recommendations according to the level of evidence and strength of recommendation
| Level | Conclusion based on |
| A | Systematic review (A1) or at least 2 independent studies with evidence level A2 (“there is evidence that…”) |
| B | One study with evidence level A2 or at least 2 independent studies with evidence level B (“it is likely that…”) |
| C | One study with evidence level B or level C (“there are indications that…”) |
| D | Expert opinion (“the working group recommends…”) |
| Level | Recommendation |
| I | Strong recommendation |
| II | Weak recommendation (suggestion) |
Classification of adhesions according to Zühlke et al.
| Grade 0 | No adhesions or insignificant adhesions |
| Grade 1 | Adhesions that are filmy and easy to separate by blunt dissection |
| Grade 2 | Adhesions where blunt dissection is possible but some sharp dissection necessary, beginning vascularization |
| Grade 3 | Lysis of adhesions possible by sharp dissection only, clear vascularization |
| Grade 4 | Lysis of adhesions possible by sharp dissection only, organs strongly attached with severe adhesions, damage of organs hardly preventable |
Fig. 1Peritoneal adhesion index. Reproduced with permission from [35]
Overview of most common applied adhesion barriers and their impact on adhesion formation and incidence of ASBO
| Barrier | Marketed as | Comments |
|---|---|---|
| Hyaluronate carboxymethylcellulose | Seprafilm® | Solid barrier most suitable for open surgery although laparoscopic placement has been described |
| Oxidized regenerated cellulose | Interceed® | Solid barrier most suitable for open surgery |
| Icodextrin | Adept® | Liquid barrier, easy to apply in both open and laparoscopic surgery |
| Polyethylene glycol | Sprayshield®/Spraygel® | Gel barrier, easy to apply in both open and laparoscopic surgery |
Adapted from [52]
Fig. 2Algorithm to diagnosis and treatment of ASBO
Overview of conclusions and recommendation
| Level A | Adhesive small bowel obstruction is a leading cause of morbidity, deaths, and healthcare expenditures in emergency surgery. |
| Level B | Adhesive small bowel obstruction causes high morbidity, with average hospital stay of 8 days and 3% in-hospital mortality per episode. Recurrence of adhesive small bowel obstruction is high. Risk for adhesive small bowel obstruction may be somewhat lower after laparoscopic compared to open colorectal surgery, but that results could not be confirmed in randomized trials. |
| Level IB | Laparoscopic surgery reduces adhesion formation and might reduce subsequent incidence of ASBO. |
| Level IA | Hyaluronate carboxymethylcellulose reduces adhesion formation and the risk of subsequent reoperations of adhesive SBO. The use of this barrier seems cost-effective in open colorectal surgery. |
| Level IIC | In the absence of signs that require emergent surgical exploration (i.e., peritonitis, strangulation, or bowel ischemia), non-operative management is the treatment strategy of choice. |
| Level IIB | A trial of non-operative management can be continued safely for 72 h. |
| Level IID | Initial evaluation should be complemented with assessment of nutritional status and laboratory tests evaluating at least blood count, lactate, electrolytes, and BUN/Creat |
| Level IIC | Plain X-rays have only limited value in the work-up of patients with small bowel obstruction and are not recommended. |
| Level IB | Optimal diagnostic work-up should include CT scan in the assessment and water soluble oral contrast. In the absence of the need to perform immediate surgery, a follow-up abdominal X-ray should be made after 24 h. If the contrast has reach the colon, this is indicative for resolution of the bowel obstruction. |
| Level IIC | Long trilumen naso-intestinal tubes are more efficacious than naso-gastric tubes in non-operative management, but require endoscopic placement. |
| Level IIC | Laparoscopic adhesiolyis might reduce morbidity in selected cases of ASBO that require surgery. Results of a randomized trial are awaited. |
| Level IIB | Adhesion barriers reduce the risk of recurrence for ASBO following operative treatment. |
| Level IIC | Younger patients, and pediatric patients in particular, have higher lifetime risk of developing adhesion-related complications and might therefore benefit most from adhesion prevention. |
| Level C | More research is needed to the impact of comorbidities in elderly patients on optimal management of adhesive small bowel obstruction. Patients with diabetes might require more early operative intervention. |